CAMLPR Transfusion Practice Test
$69.00
Unlock the full practice quiz
Get complete access to the questions, explanations and printable quiz resources.
Full access: unlock all quiz questions and explanations.
Printable review: access the full quiz PDF with correct answers after purchase.
About this Exam
Prepare with the CAMLPR Transfusion Practice Test practice quiz. This question bank includes 10 questions covering transfusion, saliva, cells, massive, and protocol. Use it to review important concepts, identify knowledge gaps, and build confidence for the related exam, course, or assessment.
Sample Questions
Question
1
What is the effect of leukoreduction on transfusion reactions?
Explanation:
Leukoreduction removes most donor white blood cells from blood products, cutting down on the immune triggers that can cause transfusion reactions. By lowering the amount of donor leukocyte antigens and the cytokines they release during storage, the recipient’s immune system is less stimulated. This leads to fewer febrile nonhemolytic transfusion reactions, which are fevers and chills driven by immune responses to leukocyte-derived substances, and less alloimmunization to HLA antigens on donor leukocytes, reducing the risk of future platelet refractoriness. It does not increase infection risk; in some high-risk situations it can reduce certain infections, such as CMV transmission via leukocytes.
Question
2
Which of the following is a key feature of a massive transfusion protocol?
Explanation:
A massive transfusion protocol is designed to rapidly replace blood loss with a balanced mix of blood components to maintain both oxygen delivery and coagulation. Transfusing only red blood cells can dilute clotting factors and platelets, leading to ongoing bleeding. Providing red cells along with plasma (for clotting factors) and platelets (for primary hemostasis) in a 1:1:1 ratio helps preserve coagulation and more closely approximates whole blood, which can improve bleeding control and outcomes when massive hemorrhage occurs. This approach emphasizes getting all components to the patient quickly rather than delaying plasma or platelets to save resources, and it avoids hypothermia, since warming blood products and maintaining normothermia are important to prevent coagulopathy.
Question
3
Which component is included in maintaining a balanced transfusion mix during a massive transfusion protocol?
Explanation:
In a massive transfusion, the goal is to replace blood components in a way that preserves coagulation while restoring oxygen delivery. Red blood cells address oxygen transport, but transfusing many RBCs without other components dilutes clotting factors and platelets, risking coagulopathy. Plasma provides the coagulation factors needed for proper clot formation, and platelets support primary hemostasis. Using a balanced 1:1:1 ratio of plasma, platelets, and red cells helps recreate a whole-blood-like mix, supporting both clotting and oxygen delivery and is associated with better outcomes in severe hemorrhage. Delaying plasma after giving RBCs, or using only RBCs, or transfusing whole blood without regard to a balanced component mix, do not maintain that critical balance.
Question
4
What is an antibody screen and how does it guide transfusion?
Explanation:
An antibody screen looks for unexpected antibodies in a patient’s plasma that could attack donor red cells. It uses screening cells that carry a broad set of common red cell antigens. If the screen is negative, the risk of a reaction is low and a crossmatch can confirm compatibility with a chosen donor unit. If the screen is positive, the specific antibody (or antibodies) is identified, revealing exactly which red cell antigen the patient’s plasma targets. Once the antibody is known, you select donor units that lack the corresponding antigen (antigen-negative for that antibody) to prevent a transfusion reaction. This process helps ensure safer transfusions and may lead to broader or extended antigen matching for future transfusions.
Question
5
Which two Rh antibodies commonly occur together?
Explanation:
RhCE antigens C/c and E/e are encoded by the same gene and tend to be inherited together on common haplotypes. Because of this genetic linkage, when a person is immunized against one of these antigens, they are often exposed to the other as well. As a result, anti-E frequently appears alongside anti-c in the same individual. This paired pattern matters in transfusion testing because detecting anti-E should prompt evaluation for anti-c too, since both can cause transfusion reactions if donor cells carry the corresponding antigens. The other pairings don’t show this consistent co-occurrence as a rule, so anti-E and anti-c is the most expected combined antibody pattern.
Ready to test your knowledge?
Buy Now to AccessAdditional Information
CAMLPR Transfusion Practice Test
This practice set contains 10 questions from the matching question bank and focuses on transfusion, saliva, cells, massive, and protocol. Work through each question carefully, review the provided solutions, and revisit topics that need more study before your next attempt.
This is an independent study resource intended for practice and review; it is not an official examination or an endorsement by any organization named in the title.
Frequently Asked Questions
This quiz contains a total of 10 practice questions carefully selected to test your knowledge on this subject.
Yes, you will have exactly 0 minutes to complete the exam. A countdown timer will be visible once you start.
Yes, you can retake this practice test as many times as you need. The questions and options may be randomized on subsequent attempts to ensure comprehensive learning.
Reviews
5.0
Based on 0 reviews
Leave a Review
No reviews yet. Be the first to review!